Law & Crime Regeneron Acquires 23andMe for $256 Million Amid Privacy Concerns and Data Breach Fallout Published 8 hours ago on May 20, 2025 By The Janitor Regeneron Pharmaceuticals confirms its acquisition of 23andMe, the once-prominent consumer genetic testing firm, for $256 million through a bankruptcy auction. The transaction is expected to close… Related Topics: Don't Miss Supreme Court Allows Trump Administration to End Temporary Protected Status for Venezuelans Continue Reading You may like Click to comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Type in the text displayed above Δ{{#message}}{{{message}}}{{/message}}{{^message}}Your submission failed. The server responded with {{status_text}} (code {{status_code}}). Please contact the developer of this form processor to improve this message. Learn More{{/message}}{{#message}}{{{message}}}{{/message}}{{^message}}It appears your submission was successful. Even though the server responded OK, it is possible the submission was not processed. Please contact the developer of this form processor to improve this message. Learn More{{/message}}Submitting…
